Photobiomodulation News

Vielight Launches COVID-19 Clinical Trial with Home-Use Device

2020-09-04T11:38:59-04:00

Toronto, Canada, Sept. 01, 2020 ( GLOBE NEWSWIRE - Link ) -- Vielight Inc. is pleased to announce the commencement of a new clinical trial in the USA. In this trial, Vielight Inc. will test the hypothesis that the recovery of patients who recently tested positive for COVID-19 infection may be accelerated by specialized light therapy. [...]

Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.

2019-05-24T13:12:05-04:00

Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.   Toronto, ON, May 22, 2019: Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial, St. Michael’s Hospital, in Toronto, has been activated. The trial will be a randomized, placebo-controlled study [...]

Go to Top